BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
News & Events
Upcoming Events.
07.01.2022
Biomedical Advanced Research & Development Authority (BARDA) Accelerator Network Collaborative Virtual Series
Art Pappas will be participating in BARDA's Accelerator Network C…
Location
virtual
09.28.2022
Women in Agribusiness Summit 2022
Karen LeVert will be participating on a panel titled "Ag Innovati…
Location
Dallas, TX
11.02.2022
Life Sciences Summit
Peter Young will be participating on a panel titled "Investor and…
Location
(virtual)
11.10.2022
The Future of the Life Sciences Industry in Wilmington, NC
Art Pappas will be participating on a panel titled "How does Wilm…
Location
Wilmington, NC
11.10.2022
NC Global Advantage Forum
Karent LeVert will be speaking at the NC Global Advantage Forum o…
Location
Research Triange Park, NC
01.10.2023
Biotech Showcase 2023
Elizabeth Kelly will be participating on a panel titled "Finance …
Location
San Francisco, CA
01.11.2023
Biotech Showcase 2023
Peter Young will be participating on a panel titled "Early Seed F…
Location
San Francisco, CA
05.11.2023
Research Triangle Partnership's 2023 State of the Region Event
Karen LeVert will be providing an overview of Ag Tech Opportuniti…
Location
Raleigh, NC
;
Congratulations to Pappas portfolio company @AuraBiosciences on their positive Phase 1 data!
Art Pappas will be speaking on a panel at @BioFuture2024! Join the discussion on the latest topics shaping the future of #healthcare alongside industry leaders and trailblazing companies. Register at http://www.BioFuture.com!
Congratulations to Kathy Glaub on her appointment to CEO of Pappas portfolio company @curaseninc !
CuraSen Therapeutics Appoints Kathleen Sereda Glaub Chief Executive Officer
CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral, rapid onset, small molecule drugs ...
www.businesswire.com
In honor of National Liver Awareness Month, we would like to share some important but jarring statistics compiled by the @HepBFoundation. HBV is not only a chronic liver condition, but it is also one of the primary causes of liver cancer.
Learn more about the work we are doing…
